Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

Flu cases have been particularly prevalent in the Wood River Valley this winter, according to St. Luke’s Wood River data.

LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...

The virus is a common respiratory illness that infects the lungs and airways. Most people experience mild symptoms, like the common cold. However, RSV can cause more severe symptoms in infants, older ...

Poland recorded over 2,600 cases of whooping cough and more than 16,000 infections with respiratory syncytial virus (RSV) in ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...